How Hushmail Can Help Your Private Therapy Practice Stay Compliant  – this blog post from Brighter Vision reviews email HIPAA risks and the advantages of encrypted email services.

FDA OKs Stimulation Device for Anxiety in Depression – the FDA expanded approval for the noninvasive BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMSTM) System to include treatment of comorbid anxiety symptoms in adult patients with depression based on data on 573 patients which “demonstrated a treatment effect that was consistent, robust, and clinically meaningful for decreasing anxiety symptoms in adult patients suffering from major depressive disorder…” From: Medscape.com

4 Key questions to consider when evaluating a digital therapeutic for anxiety – this is a detailed, and kind of pedantic/dry but informative, commentary about use of apps as an adjunctive treatment for anxiety.  It is written from the perspective of psychiatry but certainly is relevant to all therapists.  The author reviews the general lack of research about the effectiveness of these apps, and how to evaluate them for use with individual patients, such as identifying “the mechanism” of treatment.  From: PsychiatricTimes.com

Tagged on:

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.